SCHEMBL1855460

SCHEMBL1855460

FCCOc1ccccc1-c1cc2ccccn2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.64
RAB9A P51151 3/20 0.43
POLB P06746 3/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
PDE5A O76074 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
LMNA P02545 3/20 0.38
HTT P42858 1/20 0.38
HTR7 P34969 1/20 0.37
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848971 0.92 HRH3 (0.65) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL4295616 0.78 HRH3 (1.00) HRH3POLBALDH1A1SMN1; SMN2KDM4E
SCHEMBL13394694 0.78 HRH3 (0.65) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL6642828 0.77 HRH3 (0.60) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL3891998 0.77 HRH3 (0.53) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL9870817 0.74 TP53 (0.70) RAB9APOLBALDH1A1SMN1; SMN2KDM4E
SCHEMBL29753975 0.73 ALDH1A1 (0.51) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL1852097 0.71 HRH3 (0.60) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL13394698 0.70 HRH3 (0.66) HRH3RAB9APOLBNPC1ALDH1A1
SCHEMBL17620577 0.70 ALDH1A1 (0.51) HRH3RAB9APOLBNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB HRH3 4453/4885RAB9A 3454/4885POLB 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.